Verizon Communications Inc. (NYSE: VZ) – For an in-depth report on Verizon Communications Inc. follow: www.BullTrends.com/stockquote/VZ
Shares of Verizon Communications closed down 2.20% on about 618 million shares traded. The stock was one of the most active stocks on the NYSE on Monday. The company reported last week that it finally completed its buyout of Vodafone's 45 percent stake in Verizon Wireless, giving it both more independence and leaner operations.
Facebook, Inc. (NASDAQ: FB) – For an in-depth report on Facebook, Inc. follow: www.BullTrends.com/stockquote/FB
Facebook closed up 3.19% on Monday with nearly 77 million shares traded. The company’s Chief Executive Officer Mark Zuckerberg said WhatsApp Inc., which his social-media company agreed to buy last week, was "worth more than $19 billion." The mobile-messaging startup was "a great fit for us," Zuckerberg said at the Mobile World Congress in Barcelona this past weekend. "Already almost half-a-billion people love using WhatsApp for messaging and it's the most engaging app we've ever seen exist on mobile by far."
Nuvilex, Inc. (OTC: NVLX) – For an in-depth report on Nuvilex, Inc. follow: www.BullTrends.com/stockquote/NVLX
Nuvilex Inc. closed up 21.71% on Monday and even hit a new one-year high of $0.37 during intra-day trading. The stock was one of the most active stocks in the OTC market with over 43.7 million shares traded. News revealed that Lincoln Park Capital (LPC) purchased 8 million restricted shares of Nuvilex, Inc. (OTCQB: NVLX) in exchange for an initial $2 million out of what can be viewed as a $27 million "pot of money" to advance the company's late-phase pancreatic cancer clinical trials.
BioElectronics Corporation (OTC: BIEL) - For an in-depth report on BioElectronics Corporation follow: www.BullTrends.com/stockquote/BIEL
Shares of BIEL closed up 32.14% on Monday with about 1.2 billion shares traded. The stock was one of the most active stocks in the OTC market as well as one of the biggest advancers. Last week the company welcomed the FDA recommendations announced today in their Docket No. FDA-2012-N-0378, "Physical Medicine Devices; Reclassification and Renaming of Shortwave Diathermy for All Other Uses." "We are pleased that the FDA is reclassifying this technology to reflect its safety and efficacy," said Andrew J. Whelan, President, BioElectronics. The FDA's recommendation makes scientific evidence the determinant for additional market clearances."
Wondering what your next move should be in the market? BullTrends.com can help lead the way. For free access to our complete stock reports, take a few minutes to register with us by clicking this link: http://www.bulltrends.com/
Disclosure: BullTrends.com is not a registered investment advisor and nothing contained in any materials should be construed as a recommendation to buy or sell securities. Investors should always conduct their own due diligence with any potential investment. Please read our report and visit our website, for complete risks and disclosures.